Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/26/2006
 
First Published:
9/1/2000
1.
Phase III Randomized Study of Flt3 Ligand in Patients With Acute Myeloid Leukemia in Complete Remission
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
NCI
ECOG-2998
CALGB-19903, SWOG-E2998, NCT00006223, E2998
Last Modified:
5/23/2007
 
First Published:
9/1/2000
2.
Phase I/II Randomized Study of Ex Vivo Expanded Megakaryocytes in Patients With Breast Cancer or Hematologic Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 to 60
Other
NU-97B2
NCI-V00-1611, NCT00006225
Last Modified:
9/1/2002
 
First Published:
3/1/1998
3.
Phase II Study of Flt3 Ligand Alone or in Combination With Melanoma Peptide Immunization in Patients With Metastatic Melanoma or Renal Cell Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
Not specified
NCI
NCI-98-C-0040
NCI-T97-0092, T97-0092, NCT00019396
Last Modified:
7/1/2000
 
First Published:
9/1/1998
4.
Phase I Pilot Study of Flt3 Ligand Prior to Resection of Hepatic or Other Metastases of Colon Cancer (Summary Last Modified 07/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
DUMC-98032
NCI-G98-1454, NCT00003431
Last Modified:
4/3/2003
 
First Published:
6/1/2000
5.
Phase I Pilot Study of Ex Vivo Expanded Peripheral Blood Mononuclear Cells For the Elimination of Neutropenia Associated With High-Dose Chemotherapy and Conventional Autograft in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Closed
17 to 65
NCI
NU-99Z1
NCI-G00-1734, NCT00005787
Last Modified:
4/1/2002
 
First Published:
5/1/2001
6.
Phase I Study of CD40-Ligand and Flt3 Ligand in Patients With Metastatic Melanoma or Renal Cell Cancer (Summary Last Modified 04/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
16 and over
NCI
NCI-01-C-0121
NCI-1035, NCT00020540, 1035
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute